Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Stomach Neoplasms × andecaliximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1

Interventions

Oxaliplatin 51 Capecitabine 42 Fluorouracil 30 Cisplatin 30 S 1 (combination) 21 Docetaxel 16 Paclitaxel 15 Leucovorin 14 pembrolizumab 10 apatinib 10 Irinotecan 10 titanium silicide 9 XELOX 9 Nivolumab 8 Epirubicin 8 Drug Therapy 8 Hyperthermic Intraperitoneal Chemotherapy 7 Tegafur 6 Radiotherapy 6 Neoadjuvant Therapy 6 gimeracil 5 Trastuzumab 5 Chemotherapy, Adjuvant 5 Surgical Procedures, Operative 4 S-1 plus cisplatin 4 Ramucirumab 4 Gastrectomy 4 zolbetuximab 3 tislelizumab 3 sintilimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02545504 2020-05-26

GAMMA-1

Gilead Sciences

Phase 3 Completed

432 enrolled 19 charts

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡